It’s understood that around 6,000 patients could benefit from this.
The Irish Patients Association today welcomes the agreement reached between the State and the Irish Pharmaceutical Healthcare Association for a four-year medicines deal, expected to be approved by the Government.
According to Chair of the Irish Patients Association, Stephen McMahon said "This agreement addresses an unconscionable two-tier system where private patients access new cancer treatments up to two years before public patients can access the same medicine through the HSE."
For cancer medicines, it would cut delays by 514 days from the current 694-day average.
The agreement appropriately balances patients' rights to equitable access and innovation with the State's responsibility to ensure cost-effectiveness within finite health budgets.
Approximately 32 new medicines are expected this year, covering treatments for cancer, diabetes, and heart disease.
It’s understood that around 6,000 patients could benefit from this.
Maynooth's Paul Mescal Among This Years IFTA Nominees
Northern Lights Covered Kildare Skies Last Night
Curragh Community School Closes School Due To Water Supply Issue
Gardaí Issue Scam Alert For WhatsApp Calls Looking To Gather Personal Information
15 New Social Homes Open in Kilcullen
Nurses At Naas General Hospital To Take Industrial Action
€16 Million Secured For Cycling And Walking Infrastructure In Kildare
Kildare Has Second Highest Breast Cancer Survival Rate In The Country
